iCAD, Inc. (NASDAQ:ICAD) Short Interest Update

iCAD, Inc. (NASDAQ:ICAD) saw a significant increase in short interest during the month of October. As of October 15th, there was short interest totalling 235,600 shares, an increase of 8.7% from the September 30th total of 216,700 shares. Based on an average daily volume of 157,300 shares, the short-interest ratio is presently 1.5 days. Approximately 0.9% of the shares of the stock are short sold.

iCAD Trading Up 0.5 %

iCAD stock traded up $0.01 on Thursday, hitting $1.86. 89,634 shares of the stock traded hands, compared to its average volume of 163,923. iCAD has a 1 year low of $1.18 and a 1 year high of $2.65. The business’s fifty day simple moving average is $1.62 and its 200 day simple moving average is $1.50. The firm has a market cap of $49.36 million, a P/E ratio of -16.92 and a beta of 1.50.

iCAD (NASDAQ:ICAD) last released its quarterly earnings results on Tuesday, August 13th. The technology company reported ($0.07) earnings per share (EPS) for the quarter. iCAD had a negative net margin of 15.67% and a negative return on equity of 13.59%. The firm had revenue of $5.03 million for the quarter.

Institutional Trading of iCAD

Several hedge funds have recently modified their holdings of the company. Virtu Financial LLC grew its position in iCAD by 55.6% in the 1st quarter. Virtu Financial LLC now owns 21,286 shares of the technology company’s stock valued at $34,000 after acquiring an additional 7,604 shares during the last quarter. AMH Equity Ltd acquired a new position in shares of iCAD in the first quarter valued at about $207,000. Perritt Capital Management Inc raised its position in iCAD by 14.2% during the second quarter. Perritt Capital Management Inc now owns 159,900 shares of the technology company’s stock valued at $208,000 after acquiring an additional 19,917 shares in the last quarter. Essex LLC purchased a new stake in shares of iCAD in the third quarter valued at approximately $216,000. Finally, Perritt Capital Management Inc. increased its position in shares of iCAD by 7.5% in the first quarter. Perritt Capital Management Inc. now owns 139,983 shares of the technology company’s stock valued at $225,000 after buying an additional 9,717 shares in the last quarter. 24.61% of the stock is owned by hedge funds and other institutional investors.

Analyst Upgrades and Downgrades

Separately, StockNews.com upgraded shares of iCAD from a “sell” rating to a “hold” rating in a research report on Thursday, August 22nd.

iCAD Company Profile

iCAD, Inc engages in the provision of cancer detection and therapy solutions in the United States. It operates through two segments, Detection and Therapy. The company provides ProFound AI for digital breast tomosynthesis and 2D mammography; PowerLook, a density assessment solution; and ProFound Risk, a breast cancer risk analysis.